Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer.
Numerous changes in epigenetic mechanisms have been described in various types of tumors. In search for new biomarkers, we investigated the expression of Polycomb-group (PcG) proteins EZH2, BMI1 and SUZ12 and associated histone modification H3K27me3 in colorectal cancer. Nuclear expression of PcG pr...
Main Authors: | Anne Benard, Inès J Goossens-Beumer, Anneke Q van Hoesel, Hamed Horati, Hein Putter, Eliane C M Zeestraten, Cornelis J H van de Velde, Peter J K Kuppen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4171510?pdf=render |
Similar Items
-
Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma
by: Yong Jin Cho, et al.
Published: (2018-02-01) -
Increased Expression of the EZH2 Polycomb Group Gene in BMI-1-Positive Neoplastic Cells during Bronchial Carcinogenesis
by: Roderick H.J. Breuer, et al.
Published: (2004-11-01) -
EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation
by: Weipeng Mu, et al.
Published: (2018-12-01) -
The Oncogenic Polycomb Histone Methyltransferase EZH2Methylates Lysine 120 on Histone H2B and Competes Ubiquitination
by: Masaharu Kogure, et al.
Published: (2013-11-01) -
The Polycomb protein, Bmi1, regulates insulin sensitivity
by: Corey E. Cannon, et al.
Published: (2014-11-01)